MedTrace Logo

Clinical Trials

NCT04224493 | ACTIVE_NOT_RECRUITING | PHASE3
599 participants

A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2020-06-11
Completion:
2027-02-13
Conditions
  • Relapsed/Refractory Follicular Lymphoma
  • Follicular Lymphoma
  • Refractory Follicular Lymphoma
Interventions
  • DRUG
  • COMBINATION_PRODUCT
No Results Yet
NCT04197934 | ACTIVE_NOT_RECRUITING | PHASE1
56 participants

WSD0922-FU for Treatment of Glioblastoma, Anaplastic Astrocytoma, or Non-small Cell Lung Cancer With Central Nervous System Metastases

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2019-12-20
Completion:
2022-10-30
Conditions
  • Anaplastic Astrocytoma, IDH-Wildtype
  • Glioblastoma, IDH-Wildtype
  • Metastatic Lung Non-Small Cell Carcinoma
  • Metastatic Malignant Neoplasm in the Central Nervous System
  • Stage IV Lung Cancer AJCC v8
Interventions
  • PROCEDURE
  • DRUG
No Results Yet
NCT04171622 | ACTIVE_NOT_RECRUITING | PHASE2
25 participants

Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2021-11-04
Completion:
2027-08-31
Conditions
  • Metastatic Thyroid Gland Carcinoma
  • Poorly Differentiated Thyroid Gland Carcinoma
  • Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v8
  • Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v8
  • Thyroid Gland Squamous Cell Carcinoma
  • Unresectable Thyroid Gland Carcinoma
Interventions
  • DRUG
  • BIOLOGICAL
No Results Yet
NCT04106973 | TERMINATED
12 participants

Mesothelioma Early Detection by VOCs

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-10
Start Date:
2019-06-05
Completion:
2022-01-01
Conditions
  • Pleural Mesothelioma
  • Asbestos Exposure
  • Pleural Plaque
No Results Yet
NCT04044365 | ACTIVE_NOT_RECRUITING
139 participants

Pediatric cGVHD Symptom Scale

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-10
Start Date:
2019-10-02
Completion:
2026-12-31
Conditions
  • Graft vs Host Disease
No Results Yet
NCT04026516 | COMPLETED | NA
29 participants

CAVA: Dizziness Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2019-07-01
Completion:
2025-10-31
Conditions
  • Meniere's Disease
  • Benign Paroxysmal Positional Vertigo
  • Recurrent Vestibulopathy
  • Vestibular Migraine
Interventions
  • DEVICE
No Results Yet
NCT03959800 | RECRUITING
1600 participants

Molecular Basis of Pediatric Liver Cancer

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-10
Start Date:
2015-06-22
Completion:
2030-06-30
Conditions
  • Childhood Liver Cancer
  • Liver Malignant Tumors
  • Embryonal Sarcoma of Liver (Disorder)
  • Hepatoblastoma
  • Hepatocellular Carcinoma
  • Rhabdoid Tumor of Liver
No Results Yet
NCT03946878 | ACTIVE_NOT_RECRUITING | PHASE2
32 participants

Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2019-08-13
Completion:
2028-02-08
Conditions
  • Blastoid Variant Mantle Cell Lymphoma
  • CCND1 Protein Overexpression
  • CD20 Positive
  • CD5 Positive
  • FCER2 Negative
  • Pleomorphic Variant Mantle Cell Lymphoma
  • Recurrent Mantle Cell Lymphoma
  • Refractory Mantle Cell Lymphoma
  • t(11;14)(q13;q32)
Interventions
  • DRUG
No Results Yet
NCT03418818 | ACTIVE_NOT_RECRUITING | NA
70 participants

FAZA PET/MRI Sarcoma

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2018-03-27
Completion:
2028-10-31
Conditions
  • Sarcoma
Interventions
  • DRUG
No Results Yet
NCT03383575 | RECRUITING | PHASE2
63 participants

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-10
Start Date:
2018-01-17
Completion:
2027-02-28
Conditions
  • Acute Myeloid Leukemia
  • Blasts 20-30 Percent of Bone Marrow Nucleated Cells
  • Chronic Myelomonocytic Leukemia
  • IDH2 Gene Mutation
  • Myelodysplastic Syndrome With Excess Blasts
  • Recurrent High Risk Myelodysplastic Syndrome
  • Refractory High Risk Myelodysplastic Syndrome
Interventions
  • DRUG
  • OTHER
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page